BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3832216)

  • 1. [Total functional ability of patients with ankylosing spondylitis].
    Franović A; Vidmar J; Hudovsky G; Facković D; Barac D
    Reumatizam; 1985; 32(5-6):121-5. PubMed ID: 3832216
    [No Abstract]   [Full Text] [Related]  

  • 2. Diaphragmatic movement and spirometric volume in patients with ankylosing spondylitis.
    Hauge BN
    Scand J Respir Dis; 1973; 54(1):38-44. PubMed ID: 4690404
    [No Abstract]   [Full Text] [Related]  

  • 3. Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy.
    Tzelepis GE; Kalliakosta G; Tzioufas AG; Sfikakis PP; Mandros C; Boki KA; Roussos C; Moutsopoulos HM
    Ann Rheum Dis; 2009 Jun; 68(6):966-71. PubMed ID: 18633126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physical therapy of ankylosing spondylotis under ambulatory conditions].
    Thurzová E
    Fysiatr Revmatol Vestn; 1977 Aug; 55(4):223-31. PubMed ID: 561740
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in pulmonary ventilation and respiratory mechanics in patients with ankylosing spondylarthritis].
    Král J; Felkel H
    Cas Lek Cesk; 1984 Mar; 123(9):259-64. PubMed ID: 6705028
    [No Abstract]   [Full Text] [Related]  

  • 6. [Respiratory involvement in ankylosing spondylarthritis: relations to alpha-1-antitrypsin phenotypes and tobacco consumption].
    Eulry F; Marotel C; Lechevalier D; Haguenauer D; Crozes P; Magnin J
    Rev Rhum Ed Fr; 1994 Jun; 61(6):405-14. PubMed ID: 7833865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity.
    Cronstedt H; Waldner A; Stenström CH
    Scand J Rheumatol Suppl; 1999; 111():1-9. PubMed ID: 10503553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity.
    Waldner A; Cronstedt H; Stenström CH
    Scand J Rheumatol Suppl; 1999; 111():10-6. PubMed ID: 10503554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relations between spinal function and respiration in ankylosing spondylitis (Bechterew disease)].
    Meister R; Merkel T
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():691-4. PubMed ID: 6647317
    [No Abstract]   [Full Text] [Related]  

  • 11. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis.
    Stone M; Warren RW; Bruckel J; Cooper D; Cortinovis D; Inman RD
    Arthritis Rheum; 2005 Jun; 53(3):445-51. PubMed ID: 15934110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.
    Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
    J Rheumatol; 1999 Apr; 26(4):961-5. PubMed ID: 10229428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Work capacity evaluation in patients with ankylosing spondylitis].
    Grazio S; Jajić Z; Nemcić T; Jajić I
    Reumatizam; 1997; 45(2):1-5. PubMed ID: 9769720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement.
    Rejón E; Giménez MD; Mayordomo L; Rodríguez S; González MP; Marenco JL
    Scand J Rheumatol; 2004; 33(5):323-6. PubMed ID: 15513681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of 3 weeks of functional therapy on the functional capacity of the cardiovascular system in patients with ankylosing spondylitis].
    Vidmar J
    Reumatizam; 1984; 31(5-6):111-3. PubMed ID: 6535211
    [No Abstract]   [Full Text] [Related]  

  • 17. [Continuing training of patients with advanced ankylosing spondylitis].
    Hørslev-Petersen K; Rasmussen JO; Helin P
    Ugeskr Laeger; 1985 Jan; 147(2):99-101. PubMed ID: 3969741
    [No Abstract]   [Full Text] [Related]  

  • 18. Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis.
    Lubrano E; Sarzi Puttini P; Parsons WJ; D'Angelo S; Cimmino MA; Serino F; Pappone N
    Rheumatology (Oxford); 2005 May; 44(5):666-9. PubMed ID: 15757970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring disability in ankylosing spondylitis: comparison of bath ankylosing spondylitis functional index with revised Leeds Disability Questionnaire.
    Eyres S; Tennant A; Kay L; Waxman R; Helliwell PS
    J Rheumatol; 2002 May; 29(5):979-86. PubMed ID: 12022361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study.
    Pavy S; Brophy S; Calin A
    J Rheumatol; 2005 Jan; 32(1):80-5. PubMed ID: 15630730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.